[morning announcement] ① Forui shares: Furui Paris, a wholly-owned secondary subsidiary of the company, will use its own funds of 7 million euros to increase its capital by subscribing for additional shares and warrants issued by Theraclion at a subscription price of approximately 0.577 euros per share. Among them, the amount of additional shares subscribed for for the first time is 6 million euros. After the completion of the first capital increase, the company's shareholding in Theraclion will increase from 7.15% to 31.28%. Theraclion is a French company specializing in the development, manufacture and sale of echo therapy equipment for focused ultrasound (HIFU)-related therapy. The purpose of this transaction is to introduce advanced high-intensity focused ultrasound (HIFU) technologies and products owned by Theraclion to the Chinese market, especially in the non-invasive treatment of varicose veins, thyroid adenomas and breast fibromas. ② Tianqi Mould: Dongshi Automotive Technology Group Co., Ltd., the company's shareholding company, has submitted its application for initial public offering and listing on the main board to the Shenzhen Stock Exchange, which was accepted by the Shenzhen Stock Exchange on May 25th. So far, the company holds 25% of Dongshi shares. ③ Yiwei LiNeng: the application for issuing convertible bonds to unspecified objects is accepted by the Shenzhen Stock Exchange.